Erythema elevatum diutinum as a paraneoplastic syndrome in a patient with pulmonary lymphoepithelioma-like carcinoma.
A 46-year-old nonsmoking female was diagnosed with pulmonary lymphoepithelioma-like carcinoma (LELC). She simultaneously had a rare skin manifestation, erythema elevatum diutinum (EED), which did not respond to topical treatment. The patient underwent platinum-based chemotherapy and thoracic radiotherapy and had shown complete remission in both LELC and EED. EED is therefore considered as a paraneoplastic syndrome of pulmonary LELC in this case. Literature on LELC and EED were also reviewed.
JENNEREX Biotherapeutics Inc., San Francisco, 1 Market Street, Spear Tower, Suite 2260, San Francisco, CA 94105, USA. tliu@jennerex.com
Ta-Chiang
TC
Liu
I-Shu
IS
Chen
Tzu-Kai
TK
Lin
J Yu-Yun
JY
Lee
David
D
Kirn
Chao-Jung
CJ
Tsao
D000970:Antineoplastic Agents / Q000494:pharmacology; D001706:Biopsy; D002277:Carcinoma / Q000150:complications / Q000175:diagnosis*; D004890:Erythema / Q000150:complications / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000175:diagnosis*; D010984:Platinum / Q000494:pharmacology; D012074:Remission Induction; D012867:Skin / Q000473:pathology; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D010984:Platinum